Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 1.00 |
| ▸ | FAAH | O00519 | 4/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.82 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.82 |
| ▸ | MEN1 | O00255 | 1/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.82 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.71 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.71 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.71 |
| ▸ | PRKCA | P17252 | 1/20 | 0.71 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.70 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.70 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.70 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.70 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.70 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.70 |
| ▸ | CES2 | O00748 | 1/20 | 0.70 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.70 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glyceryl Monooleate SCHEMBL9754698 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL1237693 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL16083709 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL15604 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL20719833 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL18970879 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL5158478 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL20719803 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| SCHEMBL20719744 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 | |
| Glyceryl Monooleate SCHEMBL4065294 | 1.00 | DGKA (1.00) | DGKAFAAHKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119534671-A | Application of composition in preparation of medicines for diagnosing infantile hemangioma and/or monitoring progress and prognosis of infantile hemangioma | 江成鸿 | 2025-02-28 | — | — | CN | claimed |
| CN-113396332-B | Method for evaluating pregnancy progression and premature abortion for clinical intervention and use thereof | 斯坦福大学托管董事会 | 2025-02-11 | — | — | CN | claimed |
| CN-118707013-A | Method for detecting monoglyceride-MG (18:2) and monoglyceride-MG (18:1) in serum | 北京大学人民医院 | 2024-09-27 | — | — | CN | claimed |
| CN-117043603-A | Application of composition in preparation of medicines for diagnosing infantile hemangioma and/or monitoring progress and prognosis of infantile hemangioma, kit and medicines | 江成鸿 | 2023-11-10 | — | — | CN | claimed |
| CN-121577790-A | Application of metabolic marker in preparation of eye myasthenia gravis diagnostic reagent | 西安市第一医院 | 2026-02-27 | — | — | CN | disclosed |
| US-12259389-B2 | Nanoparticles and distinct exosome subsets for detection and treatment of cancer | CORNELL UNIVERSITY (US) | 2025-03-25 | — | — | US | disclosed |
| CN-119534671-A | Application of composition in preparation of medicines for diagnosing infantile hemangioma and/or monitoring progress and prognosis of infantile hemangioma | 江成鸿 | 2025-02-28 | — | — | CN | disclosed |
| CN-118707013-A | Method for detecting monoglyceride-MG (18:2) and monoglyceride-MG (18:1) in serum | 北京大学人民医院 | 2024-09-27 | — | — | CN | disclosed |
| CN-118707013-A | Method for detecting monoglyceride-MG (18:2) and monoglyceride-MG (18:1) in serum | 北京大学人民医院 | 2024-09-27 | — | — | CN | disclosed |
| CN-118707013-A | Method for detecting monoglyceride-MG (18:2) and monoglyceride-MG (18:1) in serum | 北京大学人民医院 | 2024-09-27 | — | — | CN | disclosed |
| CN-115032286-B | Application of composition in preparation of medicines for diagnosing infantile hemangioma and/or monitoring progress and prognosis of infantile hemangioma, kit and medicines | 江成鸿 | 2024-08-13 | — | — | CN | disclosed |
| US-11929171-B2 | Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-03-12 | — | — | US | disclosed |
| US-8809008-B2 | Biomarkers for impaired glucose tolerance and methods using the same | METABOLON, INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20140212380-A1 | TARGETS AND AGENTS FOR THE TREATMENT OF IMPAIRED BONE FRACTURE HEALING | UNIVERSITE LIBRE DE BRUXELLES (BE) | 2014-07-31 | — | — | US | disclosed |
| US-20130338031-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. | 2013-12-19 | — | — | US | disclosed |
| US-8546098-B2 | Biomarkers for monitoring insulin resistance and methods using the same | METABOLON, INC. (US) | 2013-10-01 | — | — | US | disclosed |
| US-20120208215-A1 | Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same | METABOLON, INC. (US) | 2012-08-16 | — | — | US | disclosed |
| US-8187830-B2 | Method for determining insulin sensitivity with biomarkers | METABOLON, INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090155826-A1 | Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same | METABOLON, INC. (US) | 2009-06-18 | — | — | US | disclosed |
| WO-2008082028-A1 | MOSQUITO REPELLENT COMPRISING AN ESTERIFIED GLYCEROL. | BIO & HNT, INC. (KR) | 2008-07-10 | — | — | WO | disclosed |